Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
Saved in:
Main Authors: | Hsin-Yu Liu, Christophe Pedros, Kok-Fai Kong, Ann J Canonigo-Balancio, Wen Xue, Amnon Altman |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6b0727518baf4f5588b97fc3c4c8adbd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular insight into isoform specific inhibition of PI3K-α and PKC-η with dietary agents through an ensemble pharmacophore and docking studies
by: Baki Vijaya Bhaskar, et al.
Published: (2021) -
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy
by: Clayton Hardman, et al.
Published: (2020) -
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
by: Wang Jiarong, et al.
Published: (2021) -
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
by: Zohreh Amoozgar, et al.
Published: (2021) -
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.
by: Anna Maria Riccio, et al.
Published: (2012)